Gene · 10219
Papers3,260
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 3,260
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Lower frequencies of circulating suppressive regulatory T cells and higher frequencies of CD4+ naïve T cells at baseline are associated with severe immune-related adverse events in immune checkpoint inhibitor-treated melanoma. | J Immunother Cancer | 2024 | 38233101 | PubTator, text mining | PubMed |
| PD-1/PD-L1 governed cross-talk of exhausted CD8+ T and memory B cells in systemic lupus erythematosus. | RMD Open | 2024 | 38233074 | PubTator, text mining | PubMed |
| Type 1 immunity enables neonatal thymic ILC1 production. | Sci Adv | 2024 | 38232171 | PubTator, text mining | PubMed |
| Bone marrow-derived mesenchymal stromal cells obstruct AML-targeting CD8+ clonal effector and CAR T-cell function while promoting a senescence-associated phenotype. | Cancer Immunol Immunother | 2024 | 38231344 | PubTator, text mining | PubMed |
| Accelarated immune ageing is associated with COVID-19 disease severity. | Immun Ageing | 2024 | 38212801 | PubTator, text mining | PubMed |
| Comparative analysis of immune infiltrates in head and neck cancers across anatomical sites. | J Immunother Cancer | 2024 | 38212122 | PubTator, text mining | PubMed |
| Breakthrough infections by SARS-CoV-2 variants boost cross-reactive hybrid immune responses in mRNA-vaccinated Golden Syrian hamsters. | PLoS Pathog | 2024 | 38198521 | PubTator, text mining | PubMed |
| Identification of key genes in chronic intermittent hypoxia-induced lung cancer progression based on transcriptome sequencing. | BMC Cancer | 2024 | 38183079 | PubTator, text mining | PubMed |
| Multimodal profiling reveals site-specific adaptation and tissue residency hallmarks of γδ T cells across organs in mice. | Nat Immunol | 2024 | 38177282 | PubTator, text mining | PubMed |
| A type 1 immunity-restricted promoter of the IL-33 receptor gene directs antiviral T-cell responses. | Nat Immunol | 2024 | 38172258 | PubTator, text mining | PubMed |
| Circulating NK cells establish tissue residency upon acute infection of skin and mediate accelerated effector responses to secondary infection. | Immunity | 2024 | 38157853 | PubTator, text mining | PubMed |
| Gut Microbiota Richness and Diversity Track With T Cell Aging in Healthy Adults. | J Gerontol A Biol Sci Med Sci | 2024 | 38123141 | PubTator, text mining | PubMed |
| Single-Cell Transcriptomics Reveals the Heterogeneity of the Immune Landscape of IDH-Wild-Type High-Grade Gliomas. | Cancer Immunol Res | 2024 | 38091354 | PubTator, text mining | PubMed |
| Single-cell transcriptomics of peripheral blood mononuclear cells indicates impaired immune and inflammatory responses in alcohol-associated hepatitis. | Hum Immunol | 2024 | 38040543 | PubTator, text mining | PubMed |
| Development of tandem antigen capture ELISAs measuring QSOX1 isoforms in plasma and serum. | Free Radic Biol Med | 2024 | 38036070 | PubTator, text mining | PubMed |
| The characterization of CD8+ T-cell responses in COVID-19. | Emerg Microbes Infect | 2024 | 37990907 | PubTator, text mining | PubMed |
| PD1+TIGIT+2B4+KLRG1+ Cells Might Underlie T Cell Dysfunction in Patients Treated with BCMA-Directed Chimeric Antigen Receptor T Cell Therapy. | Transplant Cell Ther | 2024 | 37967650 | PubTator, text mining | PubMed |
| Resident Memory-like CD8+ T Cells Are Involved in Chronic Inflammatory and Neurodegenerative Diseases in the CNS. | Neurol Neuroimmunol Neuroinflamm | 2024 | 37949669 | PubTator, text mining | PubMed |
| Timing of anti-PD-L1 antibody initiation affects efficacy/toxicity of CD19 CAR T-cell therapy for large B-cell lymphoma. | Blood Adv | 2024 | 37903325 | PubTator, text mining | PubMed |
| A first-in-human, open-label Phase 1b and a randomised, double-blind Phase 2a clinical trial in recent-onset type 1 diabetes with AG019 as monotherapy and in combination with teplizumab. | Diabetologia | 2024 | 37782353 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10219/papers?page=11